Pay in 4 interest-free payments of $5.31 Learn more
Ships within 48 hours · Estimated delivery Sep 16 - Sep 21
iqvia glp-1 prescriptions semaglutide tirzepatide q3 2024 Shortages improve for Lilly's weight loss drugs, bumping sales forecast by $3bn I-M-150847, a novel GLP-1 protocol:ipa-restricted Isolate (Flavor):Rich Chocolate
I-M-150847, a novel GLP-1 and GIP receptor dual agonist, reduces body weight gain and improves glycemic control in the rodent model of type 2 diabetes and obesity | bioRxiv
Long-acting prescription versions magnify these effects for an entire week with a single, small injection
protocol:ipa-restricted
Isolate (Flavor):Rich Chocolate
Lilly expects to apply for FDA approval of the new drug, orforglipron, by the end of the year
